XML 15 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Statements of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net loss $ (6,087,359) $ (19,274,303)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 1,961,277 3,113,831
Change in fair value of warrants (10,761,000)
Non-cash other financing costs 1,296,060  
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 3,404,856 552,521
Accounts payable 2,101,820 (2,788,377)
Accrued expenses (2,323,591) (2,836,313)
Net cash used in operating activities (10,407,937) (21,232,641)
Cash flows from financing activities:    
Proceeds from issuance of common stock, net 8,110,984 8,571,191
Proceeds from exercise of warrants 540,000  
Proceeds from exercise of stock options   8,386
Net cash provided by financing activities 8,650,984 8,579,577
Net decrease in cash and cash equivalents (1,756,953) (12,653,064)
Cash and cash equivalents, beginning of period 5,754,720 28,377,693
Cash and cash equivalents, end of period 3,997,767 $ 15,724,629
Supplemental disclosure of cash flow information:    
Reduction in value of warrants related to exercises 684,000  
Cash paid for financing costs $ 50,000